143 related articles for article (PubMed ID: 8718522)
1. Genetics and malignant progression of human brain tumours.
Furnari FB; Huang HJ; Cavenee WK
Cancer Surv; 1995; 25():233-75. PubMed ID: 8718522
[TBL] [Abstract][Full Text] [Related]
2. Emerging role of new transgenic mouse models in glioma research.
Sonabend AM; Ulasov IV; Lesniak MS
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S7-13. PubMed ID: 18076321
[TBL] [Abstract][Full Text] [Related]
3. Gliomas.
Collins VP
Cancer Surv; 1998; 32():37-51. PubMed ID: 10489622
[TBL] [Abstract][Full Text] [Related]
4. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S
Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974
[TBL] [Abstract][Full Text] [Related]
6. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
7. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
Hargrave D
Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
[TBL] [Abstract][Full Text] [Related]
8. [Towards a molecular classification of gliomas].
Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
[TBL] [Abstract][Full Text] [Related]
9. Histopathology, classification, and grading of gliomas.
Kleihues P; Soylemezoglu F; Schäuble B; Scheithauer BW; Burger PC
Glia; 1995 Nov; 15(3):211-21. PubMed ID: 8586458
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
Nicholas MK; Lukas RV; Jafri NF; Faoro L; Salgia R
Clin Cancer Res; 2006 Dec; 12(24):7261-70. PubMed ID: 17189397
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
[TBL] [Abstract][Full Text] [Related]
13. [Malignant gliomas. Oncogenic considerations].
Pérez-Ortiz L; Zaldívar-Vaillant T; Tamayo-Suárez JD
Rev Neurol; 2000 Jul 1-15; 31(1):49-52. PubMed ID: 10948584
[TBL] [Abstract][Full Text] [Related]
14. Gliomagenesis: genetic alterations and mouse models.
Holland EC
Nat Rev Genet; 2001 Feb; 2(2):120-9. PubMed ID: 11253051
[TBL] [Abstract][Full Text] [Related]
15. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas.
Varela M; Ranuncolo SM; Morand A; Lastiri J; De Kier Joffé EB; Puricelli LI; Pallotta MG
J Surg Oncol; 2004 Apr; 86(1):34-40. PubMed ID: 15048678
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses.
Alemany R; Gomez-Manzano C; Balagué C; Yung WK; Curiel DT; Kyritsis AP; Fueyo J
Exp Cell Res; 1999 Oct; 252(1):1-12. PubMed ID: 10502394
[TBL] [Abstract][Full Text] [Related]
17. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.
Godard S; Getz G; Delorenzi M; Farmer P; Kobayashi H; Desbaillets I; Nozaki M; Diserens AC; Hamou MF; Dietrich PY; Regli L; Janzer RC; Bucher P; Stupp R; de Tribolet N; Domany E; Hegi ME
Cancer Res; 2003 Oct; 63(20):6613-25. PubMed ID: 14583454
[TBL] [Abstract][Full Text] [Related]
18. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
Born PW; Broholm H; Laursen H
Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
[TBL] [Abstract][Full Text] [Related]
19. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H
Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875
[TBL] [Abstract][Full Text] [Related]
20. Role of transgenic mice in identification and characterization of tumour suppressor genes.
Sharan SK; Bradley A
Cancer Surv; 1995; 25():143-59. PubMed ID: 8718516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
